Fedrilate
Jump to navigation
Jump to search
Clinical data | |
---|---|
Trade names | Tussefan |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.041.390 |
Chemical and physical data | |
Formula | C20H29NO4 |
Molar mass | 347.455 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Fedrilate is a centrally acting cough suppressant. It was patented as a mucolytic by UCB in 1971, but was never brought to market in the US.[1] In the Netherlands, it has been marketed as Tussefan and in combination with guaifenesin as Tussefan expectorans.[2]
References
- ^ US patent 3567835, Henri Morren, "Mucolytic salts, compositions and process for treating mucus", issued March 2, 1971
- ^ Kok J, Oosterveld WJ, Sibilo SR (1979). Pharmacotherapeutisch Vademecum (in Dutch). Bussum: Romen. ISBN 90-228-8006-0.
Categories:
- CS1 Dutch-language sources (nl)
- Articles with short description
- Short description matches Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Antitussives
- 4-Morpholinyl compounds
- Carboxylate esters
- Tetrahydropyrans
- All stub articles
- Respiratory system drug stubs